All children who are receiving therapy for cancer should receive a single dose of PCV13 as soon as possible after diagnosis, regardless of prior PCV…
Our data emphasize the heterogeneity of NMC and highlights genetic aberrations that could be explored to improve therapeutic strategies.
Our approach to hematopoietic progenitor cells mobilization resulted in highly effective HPC harvest in children and adolescents with high-risk cance…
IL7 and glucocorticoids coordinately drive aberrant activation of PIM1 and suggests that T-ALL and T-LBL patients could benefit from PIM inhibition
Youth Hospital, Stockholm, Sweden Sailesh Kotecha, Cardiff University, Wales, UK Sanja Stanojevic
Early intensification with postinduction myeloid-type chemotherapy courses did not significantly improve outcome for infant acute lymphoblastic leuke…
Head, Strong Beginnings Research, Co-head Foundations of Lung Disease
Research partnership, and led by Professor Sailesh Kotecha in Cardiff. The Wal-yan Respiratory Research